Alliance Pharma downgraded by RBC after weak H2, revenue miss By Investing.com
Alliance Pharma downgraded by RBC after weak H2, revenue miss
Alliance Pharma downgraded by RBC after weak H2, revenue miss
Alliance Pharma (LON: APH) is recommending a bid of 62.5p/share by Aegros Bidco, which is owned by DBAY Affiliates and the ERES IV Fund. That values the healthcare brands...